Kshitij Manchanda, MD
Foot and Ankle Surgery · Frisco, TXNPI 1962898106
Payments from drug & device makers
Across 125 payments — averaging $276.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$13K
- Arthrex$7K
- Pylant Medical$7K
- Stryker$4K
- Southern Edge Orthopaedics, Inc.$1K
- Extremity Medical$545
- plus $2K from 10 others
What the payments were for
- Consulting fees$12,31336%
- Travel & lodging$7,78523%
- Food & beverage$3,2199%
- Education$10,75731%
- Other$5161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 14 | $12,921 |
| Arthrex | 49 | $7,263 |
| Pylant Medical | 14 | $6,502 |
| Stryker | 26 | $4,222 |
| Southern Edge Orthopaedics, Inc. | 1 | $1,200 |
| Extremity Medical | 1 | $545 |
| Integra Lifesciences Corporation | 1 | $516 |
| Vilex LLC | 1 | $500 |
| Restor3d, Inc. | 1 | $207 |
| Linvatec Corporation | 3 | $207 |
| Medical Device Business Services, Inc. | 1 | $175 |
| Smith+Nephew | 6 | $140 |
| Trilliant Surgical LLC. | 2 | $105 |
| Johnson & Johnson | 2 | $37 |
| Orthofix Medical, Inc. | 2 | $36 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEDLINE INDUSTRIES, INC.$55,013
- INBONE$2,031
- MEDLINE$2,025
- PRIME SERIES$1,553
- MEDLINE UNITE$1,013
- PENDING$1,013
- AMNIOEXCEL$516
- Fibula Nail$500
- INFINITY$171
- QUANTUM$150
How this compares
$34,590 in reported general payments places this provider in the 85th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 23 | $216 |
| Oxycodone Hcl | 26 | $188 |
| Tramadol Hcl | 13 | $59 |
| Meloxicam | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Frisco
- Leroy ButlerFrisco$117K
- Toritsenere OnosodeFrisco$55K
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.